AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent Expirations for the Week of August 14, 2022 appeared first on DrugPatentWatch - Make Better Decisions.